Your Position:Home>Products>Monoclonals/Polyclonals>Anti-Human Fibroblast activation protein alpha/FAP Reference Antibody

Anti-Human Fibroblast activation protein alpha/FAP Reference Antibody

  • Cat. No.:RB9THC440016
  • Price:Negotiable
  • Clicks:493

Product Detail

Product Parameters

FormLiquid
Host SpeciesHumanized
ClonalityMonoclonal
IsotypeIgG1-kappa
Purity>95% purity as determined by SDS-PAGE.
PurificationProtein A/G purified from cell culture supernatant.
Concentration2.8mg/ml
Endotoxin LevelPlease contact the lab for this information.
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species ReactivityHuman
TargetSurface-expressed protease, Gelatine degradation protease FAP, Integral membrane serine protease, Dipeptidyl peptidase FAP, Seprase, FAP, Post-proline cleaving enzyme, APCE, SIMP, FAPalpha, 170 kDa me
Storage Buffer0.01M PBS, pH 7.4.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Expression SystemMammalian Cells
Accession NumberQ12884
BackgroundSibrotuzumab (also known as BIBH 1) is a humanized monoclonal antibody (mAb) which has the high affinity to bind to fibroblast activation protein (FAP), which is highly expressed by stroma cells of tumors. In addition, it was intended and developed by Boehringer Ingelheim Pharma KG for the treatment of cancer. Firstly, this drug was designed to fight against various malignancies, such as colorectal, non-small cell lung, breast, as well as head and neck cancer. However, it is disappointing that in 2003 it failed a phase II clinical trial for metastatic colorectal cancer. At present, there is no relevant clinically approved information disclosure.
• The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis., PMID:39364020
• Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin., PMID:21251197
• Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein., PMID:16223769
• Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV., PMID:17174263
• Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design., PMID:19402713
• Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA., PMID:23932048
• Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis., PMID:24034420
Alternative NamesBIBH1, 216669-97-5
NoteFor research use only. Not suitable for clinical or therapeutic use.
For Research Use Only. Not for Diagnostic Procedures.

Related Products:
Total 33055 records,Divided into 1653 pages,The 1 pages | First Prev Next Last
Live Chat
  • Tel:
  • WeChat ID: 15898894496
  • Add Message
  • 9:00 AM – 6:00 PM